Involvement of dimethylarginine dimethylaminohydrolase type 1 (DDAH1) in addiction and social stress phenotypes: Insights from proteomic, metabolomic and functional studies

Miroslav N. Nenov, Lisa A. Briand

Open source

DOI
10.1016/j.pnpbp.2025.111568
Published
2025-12
Container
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.pnpbp.2025.111568,
  title = {Involvement of dimethylarginine dimethylaminohydrolase type 1 (DDAH1) in addiction and social stress phenotypes: Insights from proteomic, metabolomic and functional studies},
  author = {Miroslav N. Nenov and Lisa A. Briand},
  year = {2025},
  journal = {Progress in Neuro-Psychopharmacology and Biological Psychiatry},
  doi = {10.1016/j.pnpbp.2025.111568},
  url = {https://doi.org/10.1016/j.pnpbp.2025.111568}
}

RIS

TY  - JOUR
TI  - Involvement of dimethylarginine dimethylaminohydrolase type 1 (DDAH1) in addiction and social stress phenotypes: Insights from proteomic, metabolomic and functional studies
AU  - Miroslav N. Nenov
AU  - Lisa A. Briand
PY  - 2025
JO  - Progress in Neuro-Psychopharmacology and Biological Psychiatry
DO  - 10.1016/j.pnpbp.2025.111568
UR  - https://doi.org/10.1016/j.pnpbp.2025.111568
ER  - 

APA

Nenov, M. N., & Briand, L. A. (2025). Involvement of dimethylarginine dimethylaminohydrolase type 1 (DDAH1) in addiction and social stress phenotypes: Insights from proteomic, metabolomic and functional studies. Progress in Neuro-Psychopharmacology and Biological Psychiatry. https://doi.org/10.1016/j.pnpbp.2025.111568

Source records